The purpose of this study is to evaluate the activity of an investigational medication in relapsed or refractory non-seminomatous germ cell tumors (NSGCT). Germ cell tumors are a type of cancer that begins in the cells that give rise to sperm or eggs. This study investigates how the investigational medication affects these tumors.
Participants in the study will undergo specific procedures to assess the effectiveness of the investigational medication. These procedures are designed to monitor the response of the germ cell tumors to the treatment.
- Who can participate: Participants must have relapsed or refractory non-seminomatous germ cell tumors. Age criteria and additional eligibility factors will be provided by the study coordinators.
- Study details: Participants will receive an investigational medication to see how it affects their germ cell tumors.
